635 related articles for article (PubMed ID: 30655369)
1. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
2. Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation.
Guerrero JA; Kyei M; Russell S; Liu J; Gartner TK; Storrie B; Ware J
Blood; 2009 Dec; 114(27):5541-6. PubMed ID: 19808696
[TBL] [Abstract][Full Text] [Related]
3. Altered megakaryocytopoiesis in von Willebrand type 2B disease.
Nurden AT; Federici AB; Nurden P
J Thromb Haemost; 2009 Jul; 7 Suppl 1():277-81. PubMed ID: 19630816
[TBL] [Abstract][Full Text] [Related]
4. The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse.
Kanaji S; Morodomi Y; Weiler H; Zarpellon A; Montgomery RR; Ruggeri ZM; Kanaji T
Haematologica; 2022 Sep; 107(9):2133-2143. PubMed ID: 35142156
[TBL] [Abstract][Full Text] [Related]
5. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B.
Nurden P; Gobbi G; Nurden A; Enouf J; Youlyouz-Marfak I; Carubbi C; La Marca S; Punzo M; Baronciani L; De Marco L; Vitale M; Federici AB
Blood; 2010 Apr; 115(13):2649-56. PubMed ID: 20118404
[TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway.
Bury L; Falcinelli E; Mezzasoma AM; Guglielmini G; Momi S; Gresele P
Haematologica; 2022 Jul; 107(7):1643-1654. PubMed ID: 34407603
[TBL] [Abstract][Full Text] [Related]
7. Terminal platelet production is regulated by von Willebrand factor.
Poirault-Chassac S; Nguyen KA; Pietrzyk A; Casari C; Veyradier A; Denis CV; Baruch D
PLoS One; 2013; 8(5):e63810. PubMed ID: 23737952
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
[TBL] [Abstract][Full Text] [Related]
9. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.
Nurden P; Debili N; Vainchenker W; Bobe R; Bredoux R; Corvazier E; Combrie R; Fressinaud E; Meyer D; Nurden AT; Enouf J
Blood; 2006 Oct; 108(8):2587-95. PubMed ID: 16720832
[TBL] [Abstract][Full Text] [Related]
10. Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.
Slayton WB; Patel M; Sola-Visner M; Harris N; Rivers A; Montgomery RR; Friedman KD
J Pediatr Hematol Oncol; 2008 Sep; 30(9):708-11. PubMed ID: 18776767
[TBL] [Abstract][Full Text] [Related]
11. Refrigeration-Induced Binding of von Willebrand Factor Facilitates Fast Clearance of Refrigerated Platelets.
Chen W; Druzak SA; Wang Y; Josephson CD; Hoffmeister KM; Ware J; Li R
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2271-2279. PubMed ID: 29097365
[TBL] [Abstract][Full Text] [Related]
12. Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes.
Balduini A; Pallotta I; Malara A; Lova P; Pecci A; Viarengo G; Balduini CL; Torti M
J Thromb Haemost; 2008 Nov; 6(11):1900-7. PubMed ID: 18752571
[TBL] [Abstract][Full Text] [Related]
13. A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.
Ghevaert C; Salsmann A; Watkins NA; Schaffner-Reckinger E; Rankin A; Garner SF; Stephens J; Smith GA; Debili N; Vainchenker W; de Groot PG; Huntington JA; Laffan M; Kieffer N; Ouwehand WH
Blood; 2008 Apr; 111(7):3407-14. PubMed ID: 18065693
[TBL] [Abstract][Full Text] [Related]
14. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
[TBL] [Abstract][Full Text] [Related]
15. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
16. Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model.
Poujol C; Ware J; Nieswandt B; Nurden AT; Nurden P
Exp Hematol; 2002 Apr; 30(4):352-60. PubMed ID: 11937271
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.
Casari C; Paul DS; Susen S; Lavenu-Bombled C; Harroche A; Piatt R; Poe KO; Lee RH; Bryckaert M; Christophe OD; Lenting PJ; Denis CV; Bergmeier W
Blood Adv; 2018 Jun; 2(12):1417-1428. PubMed ID: 29925524
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome.
Strassel C; Eckly A; Léon C; Petitjean C; Freund M; Cazenave JP; Gachet C; Lanza F
Haematologica; 2009 Jun; 94(6):800-10. PubMed ID: 19377075
[TBL] [Abstract][Full Text] [Related]
20. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
Castaman G; Federici AB
Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]